BIOS.ST
Price:
$0.016
Market Cap:
$1.41M
Bioservo Technologies AB (publ) develops and sells wearable muscle strengthening systems worldwide. It offers Ironhand, a robotic grip that strengthens gloves, and Carbonhand that provides enhanced hand function. The company's products have applications in logistics, warehousing, construction, and healthcare sectors, as well as used in pre-assembly and assembly tasks. Bioservo Technologies AB (publ) was incorporated in 2003 and is based in Kista, Sweden.
Industry
Medical - Instruments & Supplies
IPO Date
2017-05-22
Stock Exchange
STO
Ticker
BIOS.ST
According to Bioservo Technologies AB (publ)’s latest financial reports and current stock price. The company's current ROE is -100.76%. This represents a change of 220.28% compared to the average of -31.46% of the last 4 quarters.
The mean historical ROE of Bioservo Technologies AB (publ) over the last ten years is -58.60%. The current -100.76% ROE has changed 71.94% with respect to the historical average. Over the past ten years (40 quarters), BIOS.ST's ROE was at its highest in in the March 2016 quarter at 0%. The ROE was at its lowest in in the December 2022 quarter at -42.38%.
Average
-58.60%
Median
-48.74%
Minimum
-134.80%
Maximum
-29.86%
Discovering the peaks and valleys of Bioservo Technologies AB (publ) ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 144.03%
Maximum Annual ROE = -29.86%
Minimum Annual Increase = -55.53%
Minimum Annual ROE = -134.80%
| Year | ROE | Change |
|---|---|---|
| 2022 | -134.80% | 144.03% |
| 2021 | -55.24% | 30.77% |
| 2020 | -42.24% | 36.73% |
| 2019 | -30.89% | -55.53% |
| 2018 | -69.47% | 132.66% |
| 2017 | -29.86% | -29.29% |
| 2016 | -42.23% | -34.11% |
The current ROE of Bioservo Technologies AB (publ) (BIOS.ST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-77.42%
5-year avg
-66.53%
10-year avg
-58.60%
Bioservo Technologies AB (publ)’s ROE is less than Bonesupport Holding AB (publ) (19.60%), less than Artificial Solutions International AB (publ) (25.54%), greater than Fluicell AB (publ) (-45.98%), greater than Asarina Pharma AB (publ) (-157.86%), greater than ChromoGenics AB (-92.73%),
| Company | ROE | Market cap |
|---|---|---|
| 19.60% | $12.28B | |
| 25.54% | $150.23M | |
| -45.98% | $14.56M | |
| -157.86% | $633.96K | |
| -92.73% | $64.98M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bioservo Technologies AB (publ) using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Bioservo Technologies AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Bioservo Technologies AB (publ)'s ROE?
How is the ROE calculated for Bioservo Technologies AB (publ) (BIOS.ST)?
What is the highest ROE for Bioservo Technologies AB (publ) (BIOS.ST)?
What is the 3-year average ROE for Bioservo Technologies AB (publ) (BIOS.ST)?
What is the 5-year average ROE for Bioservo Technologies AB (publ) (BIOS.ST)?
How does the current ROE for Bioservo Technologies AB (publ) (BIOS.ST) compare to its historical average?